Back to top

Labcorp announces nationwide availability of ColoSense

Labcorp (LH) announced the nationwide availability of ColoSense, the only RNA-based at-home test for colorectal cancer screening approved by the U....

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Labcorp Holdings Inc. (LH)